Glenview Trust CO Astrazeneca PLC Transaction History
Glenview Trust CO
- $5.27 Billion
- Q4 2024
A detailed history of Glenview Trust CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Glenview Trust CO holds 4,413 shares of AZN stock, worth $298,274. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,413
Previous 4,430
0.38%
Holding current value
$298,274
Previous $345,000
16.23%
% of portfolio
0.01%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding AZN
# of Institutions
1,378Shares Held
476MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.08 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$2.77 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.54 Billion0.48% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.62 Billion0.13% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.32 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $209B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...